JPWO2021079120A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021079120A5 JPWO2021079120A5 JP2022523914A JP2022523914A JPWO2021079120A5 JP WO2021079120 A5 JPWO2021079120 A5 JP WO2021079120A5 JP 2022523914 A JP2022523914 A JP 2022523914A JP 2022523914 A JP2022523914 A JP 2022523914A JP WO2021079120 A5 JPWO2021079120 A5 JP WO2021079120A5
- Authority
- JP
- Japan
- Prior art keywords
- chain
- tcr
- seq
- acid sequence
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1915359.2 | 2019-10-23 | ||
| GB201915359A GB201915359D0 (en) | 2019-10-23 | 2019-10-23 | Engineered regulatory t cell |
| PCT/GB2020/052657 WO2021079120A1 (en) | 2019-10-23 | 2020-10-22 | Engineered regulatory t cell |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022553379A JP2022553379A (ja) | 2022-12-22 |
| JPWO2021079120A5 true JPWO2021079120A5 (https=) | 2023-10-19 |
| JP2022553379A5 JP2022553379A5 (https=) | 2023-10-19 |
Family
ID=68728329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523914A Pending JP2022553379A (ja) | 2019-10-23 | 2020-10-22 | 操作された制御性ｔ細胞 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220363733A1 (https=) |
| EP (1) | EP4048687A1 (https=) |
| JP (1) | JP2022553379A (https=) |
| CN (1) | CN114641487A (https=) |
| AU (1) | AU2020371991A1 (https=) |
| CA (1) | CA3154615A1 (https=) |
| GB (1) | GB201915359D0 (https=) |
| WO (1) | WO2021079120A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019254824B2 (en) * | 2018-04-18 | 2025-04-24 | Ucl Business Ltd | Method for enhancing the suppressive properties of Treg cells |
| EP4519417A1 (en) * | 2022-05-05 | 2025-03-12 | Quell Therapeutics Limited | Method for maintaining suppressive activity of regulatory t cells |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2825261B1 (fr) | 2001-06-01 | 2003-09-12 | Maco Pharma Sa | Ligne de prelevement du sang placentaire comprenant une poche de rincage |
| US7147626B2 (en) | 2004-09-23 | 2006-12-12 | Celgene Corporation | Cord blood and placenta collection kit |
| CN110139873A (zh) * | 2016-10-03 | 2019-08-16 | 朱诺治疗学股份有限公司 | Hpv特异性结合分子 |
| AU2019254824B2 (en) * | 2018-04-18 | 2025-04-24 | Ucl Business Ltd | Method for enhancing the suppressive properties of Treg cells |
-
2019
- 2019-10-23 GB GB201915359A patent/GB201915359D0/en not_active Ceased
-
2020
- 2020-10-22 CN CN202080074667.XA patent/CN114641487A/zh active Pending
- 2020-10-22 WO PCT/GB2020/052657 patent/WO2021079120A1/en not_active Ceased
- 2020-10-22 CA CA3154615A patent/CA3154615A1/en active Pending
- 2020-10-22 US US17/771,465 patent/US20220363733A1/en active Pending
- 2020-10-22 JP JP2022523914A patent/JP2022553379A/ja active Pending
- 2020-10-22 EP EP20800252.7A patent/EP4048687A1/en active Pending
- 2020-10-22 AU AU2020371991A patent/AU2020371991A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021520831A5 (https=) | ||
| TWI803910B (zh) | 新型t細胞受體及其免疫治療應用 | |
| TWI736719B (zh) | 新型t 細胞受體及其免疫治療應用 | |
| JP2022050400A (ja) | 抗ｋｒａｓ－ｇ１２ｄ ｔ細胞受容体 | |
| JP2019536430A5 (https=) | ||
| TW201839010A (zh) | T細胞受體及其針對prame陽性癌症的免疫治療 | |
| TW201827460A (zh) | 改善配對的ｔ細胞受體 | |
| TW201904989A (zh) | 新型t細胞受體及其免疫治療 | |
| JP2020511115A5 (https=) | ||
| CZ328895A3 (en) | Monoclonal antibody, fragment thereof, process for preparing such monoclonal antibody and pharmaceutical composition containing thereof | |
| JP2020537515A5 (https=) | ||
| TW201806973A (zh) | 新穎t細胞受器及使用其之免疫治療 | |
| JP2020500523A5 (https=) | ||
| JP2012095650A (ja) | 糸球体腎炎および他の炎症性疾患の治療のための組成物および方法 | |
| JP6907229B2 (ja) | ヒト化抗ｃｌｅｖｅｒ−１抗体およびその使用 | |
| CN108934169A (zh) | 用于抑制因子d的组合物和方法 | |
| JPWO2019202322A5 (https=) | ||
| JPWO2020059847A5 (https=) | ||
| JPWO2021155380A5 (https=) | ||
| JP2022512901A (ja) | Ｂ細胞を活性化するｃｄ７３抗体 | |
| CA3210599A1 (en) | Modulation of wnt signaling in gastrointestinal disorders | |
| CN109414426A (zh) | 使用精氨酸耗竭剂的组合癌症免疫疗法 | |
| CA2522994A1 (en) | Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer | |
| CN110964750A (zh) | 携带基因元件组合的嵌合抗原受体细胞文库、制备和筛选方法及用途 | |
| WO2025001335A1 (zh) | 一种缺血性心脏病晚期纤维化干预靶点及其应用 |